Amnode (AMNO) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
15 Aug, 2025Executive summary
Revenue for Q2 2025 was 12.6 MSEK, down 44% year-over-year, with EBITDA at -3.5 MSEK compared to 0.8 MSEK last year.
H1 2025 revenue totaled 26.3 MSEK, a 40% decrease year-over-year, and EBITDA was -4.8 MSEK versus 2.1 MSEK.
Net loss after tax for Q2 was -4.7 MSEK, and for H1 -7.2 MSEK; EPS for H1 was -2.13 SEK.
Significant cost reductions and operational adjustments were implemented, including staff reductions and equipment investments.
A rights issue was completed, resulting in a new majority shareholder and mandatory bid obligation.
Financial highlights
Q2 2025 EBITDA margin was -27.8% versus 3.7% last year; operating margin was -32.9% versus 0.6%.
H1 2025 operating margin was -22.9% compared to 2.0% year-over-year.
Cash flow from operations for H1 was -1.7 MSEK, down from 1.5 MSEK last year.
Net debt increased to 16.5 MSEK from 12.6 MSEK at year-end 2024.
Equity ratio at June 30, 2025, was 13%, down from 37% a year earlier.
Outlook and guidance
Management expects cost and productivity improvements from recent staff reductions and equipment upgrades.
Market conditions remain challenging, but new customer inquiries and operational improvements provide cautious optimism for H2.
Latest events from Amnode
- 2025 saw lower sales and losses, but Q4 performance improved and delisting was announced.AMNO
Q4 20256 Feb 2026 - Profitability improved in Q3, with delisting and new capital to support future flexibility.AMNO
Q3 202514 Nov 2025 - Sharp revenue drop and losses amid operational disruptions, but order intake remains stable.AMNO
Q3 202413 Jun 2025 - Sales fell but profitability improved as Amnode adapts to new markets and operational changes.AMNO
Q2 202413 Jun 2025 - Sales and earnings declined sharply as market delays and liquidity challenges persisted.AMNO
Q1 20256 Jun 2025 - Revenue and margins fell sharply in 2024; liquidity actions and new customers targeted.AMNO
Q4 20246 Jun 2025